SXTP insider buying and SEC filings, explained
60 Degrees Pharmaceuticals, Inc. · CIK 1946563
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$22K
Insiders who bought
1
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jun 12, 2026 | Purchase (code P) | Geoffrey S. Dow (CEO and Director) bought 7,350 shares at $1.38 ($10K), reported as a purchase (code P). Holdings up 44% to 24,131 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 15, 2026 |
| Dec 15, 2025 | Purchase (code P) | Geoffrey S. Dow (CEO and Director) bought 9,670 shares at $0.8000 ($8K), reported as a purchase (code P). Holdings up 19% to 59,618 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 16, 2025 |
| Dec 10–11, 2025 | Purchase (code P) | Geoffrey S. Dow (CEO and Director) bought 12,963 shares between Dec 10, 2025 and Dec 11, 2025 at about $0.9416 ($12K), reported as a purchase (code P). Holdings up 35% to 49,948 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 12, 2025 |
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow SXTP in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.